ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 83 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $39,000 | -27.8% | 13,524 | -5.5% | 0.00% | – |
Q4 2019 | $54,000 | -26.0% | 14,305 | +0.3% | 0.00% | – |
Q3 2019 | $73,000 | -18.0% | 14,257 | -0.7% | 0.00% | – |
Q2 2019 | $89,000 | -11.9% | 14,357 | +1.2% | 0.00% | – |
Q1 2019 | $101,000 | -19.2% | 14,191 | -3.1% | 0.00% | -100.0% |
Q4 2018 | $125,000 | -57.2% | 14,652 | +0.5% | 0.00% | 0.0% |
Q3 2018 | $292,000 | -21.1% | 14,573 | +1.8% | 0.00% | 0.0% |
Q2 2018 | $370,000 | +40.7% | 14,311 | +30.2% | 0.00% | 0.0% |
Q1 2018 | $263,000 | -22.9% | 10,988 | +9.3% | 0.00% | 0.0% |
Q4 2017 | $341,000 | +63.9% | 10,056 | +2.4% | 0.00% | 0.0% |
Q3 2017 | $208,000 | +30.8% | 9,823 | +8.1% | 0.00% | 0.0% |
Q2 2017 | $159,000 | -11.7% | 9,089 | -11.6% | 0.00% | 0.0% |
Q1 2017 | $180,000 | +11.1% | 10,284 | +7.1% | 0.00% | 0.0% |
Q4 2016 | $162,000 | -99.9% | 9,602 | -0.3% | 0.00% | 0.0% |
Q3 2016 | $157,979,000 | +8.5% | 9,627 | +0.1% | 0.00% | 0.0% |
Q2 2016 | $145,541,000 | +65.4% | 9,613 | +57.9% | 0.00% | – |
Q1 2016 | $88,000,000 | -48.8% | 6,087 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $172,000,000 | +168527.5% | 6,087 | -0.2% | 0.00% | – |
Q3 2015 | $102,000 | -99.9% | 6,098 | +0.1% | 0.00% | -100.0% |
Q2 2015 | $159,706,000 | +397.1% | 6,091 | +231.6% | 0.00% | – |
Q1 2015 | $32,129,000 | +0.7% | 1,837 | 0.0% | 0.00% | – |
Q4 2014 | $31,909,000 | -10.3% | 1,837 | -3.9% | 0.00% | – |
Q3 2014 | $35,583,000 | +1.9% | 1,911 | 0.0% | 0.00% | – |
Q2 2014 | $34,933,000 | – | 1,911 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,601,351 | $43,963,000 | 9.03% |
Granite Point Capital Management, L.P. | 256,031 | $4,327,000 | 3.45% |
Opaleye Management Inc. | 285,000 | $4,817,000 | 2.84% |
Brenner West Capital Advisors | 1,221,463 | $20,643,000 | 2.28% |
ARMISTICE CAPITAL, LLC | 536,000 | $9,058,000 | 2.14% |
NEXTHERA CAPITAL LP | 151,670 | $2,563,000 | 1.50% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 185,234 | $3,130,000 | 1.41% |
Cheyne Capital Management (UK) LLP | 144,765 | $2,448,000 | 1.38% |
SPHERA FUNDS MANAGEMENT LTD. | 270,000 | $4,563,000 | 1.16% |
Mosaic Family Wealth, LLC | 123,314 | $2,084,000 | 0.96% |